Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross-Sectional Survey [0.03%]
澳大利亚社区药剂师进行HCV检测和治疗的准备情况调查研究
Elissa Ong,Ting Xia,Rose Laing et al.
Elissa Ong et al.
The World Health Organisation (WHO) has set goals to eliminate hepatitis C (HCV) as a global health threat by 2030. To meet this goal, Australia must increase testing and diagnosis, including expanding access to care through community pharm...
Long-Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta-Analysis [0.03%]
乙型肝炎疫苗接种后的长期免疫力和再次免疫反应：系统评价和meta分析
Hannah Ramrakhiani,Michael H Le,Leslie Kam et al.
Hannah Ramrakhiani et al.
Using a systematic review and meta-analytic approach, this study determined the durability of HBV immunity and the prevalence of anamnestic response to a booster HBV vaccine dose in individuals previously vaccinated with a 3-dose HBV vaccin...
Meta-Analysis
Journal of viral hepatitis. 2025 Feb;32(2):e70003. DOI:10.1111/jvh.70003 2025
Evaluating Hepatitis B Screening During Pregnancy: A Study on Diagnostic Accuracy and Infection Control in Nigeria [0.03%]
尼日利亚孕期乙型肝炎筛查的诊断准确性和感染控制研究评估
Chinomso Joel Ukagebu,Jude Oluwapelumi Alao,Favour Oluwadara Bamigboye et al.
Chinomso Joel Ukagebu et al.
Hepatitis B virus (HBV) remains a critical public health issue in low- and middle-income countries (LMICs), particularly among pregnant women in Nigeria. Routine screening using rapid diagnostic kits is common in antenatal care, yet the acc...
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy [0.03%]
DAAs-PASS：直接抗病毒治疗后肝细胞癌复发的前瞻性评价
Amit G Singal,K Rajender Reddy,Massimo Colombo et al.
Amit G Singal et al.
Direct-acting antiviral (DAA) therapy is associated with a significant reduction in hepatocellular carcinoma (HCC) incidence among patients with cirrhosis, but data are conflicting about the risk of recurrence following DAA therapy. DAA-PAS...
Observational Study
Journal of viral hepatitis. 2025 Feb;32(2):e14056. DOI:10.1111/jvh.14056 2025
Heterogeneity in Risk and Implications for Hepatitis C Reinfection in People Who Inject Drugs in England [0.03%]
英格兰注射毒品者肝炎C风险的异质性及其再感染的 implications
Bryn Hilton,Daniela De Angelis,Holly Mitchell et al.
Bryn Hilton et al.
Chronic hepatitis C virus (HCV) infection is associated with significant morbidity, mortality and health economic burden. Over 90% of HCV cases in England occur in people who inject drugs (PWID). Current treatments for HCV are effective but...
Alexis S Voeller,Asgeir Johannessen,Zebideru Zewdie Abebe et al.
Alexis S Voeller et al.
As the second most populated country in Africa, Ethiopia needs public health measures to control diseases that impact its population. The goal of this study is to analyse disease burdens of HBV and HCV, while also highlighting their estimat...
Immunotherapy Using HBV Vaccine Pulsed DCs and Induced T-Cells Combined Antiviral Drugs in Treatment Naive CHB Patients-A Multi-Centre Phase II Study [0.03%]
HBV疫苗负载DC和诱导T细胞联合抗病毒药物治疗初治慢性乙肝患者多中心II期临床研究
Yurong Gu,Lin Gu,Lubiao Chen et al.
Yurong Gu et al.
Dendritic cells are the most potent antigen-presenting cells in immune therapeutic approaches for chronic hepatitis B (CHB) infection. Here, we developed a clinical trial to evaluate the efficacy and safety of autologous HBV vaccine-pulsed ...
Clinical Trial
Journal of viral hepatitis. 2025 Feb;32(2):e14045. DOI:10.1111/jvh.14045 2025
Patient Source of Referral Is a Key Determinant of Subsequent Retention in Care for Young Chronic Hepatitis B Patients [0.03%]
慢性乙肝年轻患者后续治疗依从性的重要影响因素：患者的来源决定后续留档率
David Mutimer,Maxine Brown,Jacqueline Logan et al.
David Mutimer et al.
Hepatitis B elimination objectives can only be realised if new patient linkage to care is matched by long-term patient retention in care. We previously showed in adult chronic hepatitis B (CHB) patients that retention in care was inferior i...
Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment Outcomes in Canada: A CanHepC-CANUHC Analysis [0.03%]
加拿大丙型肝炎治疗结局的抗药性关联取代检测趋势和影响：CanHepC-CANUHC分析结果
Himain Perera,Haris Imsirovic,Gisela Macphail et al.
Himain Perera et al.
Resistance-associated substitutions (RASs) are mutations within the hepatitis C (HCV) genome that may influence the likelihood of achieving a sustained virological response (SVR) with direct acting antiviral (DAA) treatment. Clinicians cond...
Optimization of the Use of APRI and FIB-4 for Ruling Out Liver Cirrhosis in Chronic Hepatitis B Patients With Normal Alanine Aminotransferase [0.03%]
优化APRI和FIB-4在排除慢性乙型肝炎患者正常ALT水平血清学肝硬化的应用价值研究
Zhiyi Zhang,Jian Wang,Li Zhu et al.
Zhiyi Zhang et al.
The exclusion of cirrhosis is important in chronic hepatitis B (CHB) patients with normal alanine aminotransferase (ALT). We aimed to optimise the performance of the aspartate aminotransferase to platelet ratio index (APRI) and fibrosis sco...